met

HYUNDAI MOTOR COMPANY PRESIDENT AND CEO JOS MUOZ SHARES STRATEGIC VISION FOR 2026 AT 2025 LEADERS TALK

Hyundai Motor CEO José Muñoz emphasised resilience, adaptability, and cross-functional alignment as key strengths to confidently lead future mobilityMuñoz shared…

3 days ago

XCMG Deepens South America Ties with Localization Push, New Hubs, and Sustainable Mining Partnerships

POUSO ALEGRE, Brazil, Nov. 4, 2025 /PRNewswire/ -- Yang Dongsheng, Chairman of XCMG Machinery, met Brazilian President Lula at the Presidential…

5 days ago

Ultima Markets and Inter Bring Their Partnership from Screen to Stadium

MILAN, Oct. 31, 2025 /PRNewswire/ -- Ultima Markets celebrated its Regional Partnership for the Asian territory with FC Internazionale Milano…

1 week ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

2 weeks ago

Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference

October 24, 2025 07:00 ET  | Source: Sagimet Biosciences Inc. Denifanstat met all primary and secondary endpoints versus placebo and…

2 weeks ago

Netrack Highlights iRack Innovation at BICSI India Technology Seminar 2025 in Chennai

Netrack participated in the BICSI event in Chennai. Being the leading provider of data center and IT infrastructure solutions, Netrack…

3 weeks ago

LANZAJET AND KAZMUNAYGAS (KMG) ANNOUNCE KAZAKHSTAN’S FIRST SUSTAINABLE AVIATION FUEL PROJECT PASSES MAJOR MILESTONE AND ADVANCES TO ENGINEERING AND DESIGN PHASE

As part of New York Climate Week, LanzaJet's CEO addressed the President of the Republic of Kazakhstan and met with…

2 months ago

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…

2 months ago

Water Crisis to Water Security: The Art of Living’s Scalable Model for a Water Positive India

BENGALURU, India, Aug. 26, 2025 /PRNewswire/ -- Water is India's lifeline - and its looming crisis. With 80% of the…

3 months ago

Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients

August 21, 2025 01:30 ET  | Source: NICOX SA Press Release Nicox Announces Positive Results from the NCX 470 Phase…

3 months ago